Search your symptoms with MEDgle. You can check your symptoms. It is a medical symptom search allowing you find out what options make sense for you.
CLOSE
PATIENT GPS
patients
healthcare providers
how it works
about
login
edit search
new search
symptoms
diagnoses
physicians
drugs
procedures
close
symptoms
diagnoses
drugs
procedures
physicians
symptom duration
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
add symptom to current symptom search
same as above
0-3 days
4-14 days
2 weeks-2 months
2-6 months
6 months +
gender
male
female
age
1-3
4-11
12-17
18-29
30-50
50+
age
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
calculate
visual
[hide visual search]
search visually
symptoms
|
diagnoses
|
drugs
|
procedures
|
physicians
search symptoms
•
Find causes for your symptoms
•
Discover relevant types of physicians
search diagnoses
•
Understand the details of a diagnosis
•
Learn about relevant tests and treatments
•
Find useful resources on the web
search drugs
•
Learn about different therapeutic drugs
•
Understand what they are used for
•
Know the potential options
search procedures
•
Learn about different diagnostic and therapeutic procedures
•
Understand what they are used for
•
Know the potential options
search physicians
•
Find physicians in your area
•
Understand what they do
•
Get the right help you need
lymphokine-activated killer cell therapy
reduced results from
147 billion
41 million
1 million
13851
to ~253 options
options split into images, definition, symptoms, related diagnoses, diagnostic tests, therapies, and medications
what is 'lymphokine-activated killer cell therapy'?
Definition for Lymphokine-activated killer cell therapy
Lymphokine-activated killer cell therapy is a medical procedure used for such diagnoses as: metastases.
related diagnosis for 'lymphokine-activated killer cell therapy'
1 - 1 of
1
diagnosis
metastases
spread of malignant tumors to other body sites
Lymphokine-activated killer cell therapy and metastases
related procedure for 'lymphokine-activated killer cell therapy'/associated diagnoses
1 - 5 of
171
procedures
Abdominal CAT Scan
Lymphokine-activated killer cell therapy and Abdominal CAT Scan
Abdominal MRI
MRI of abdominal contents
Lymphokine-activated killer cell therapy and Abdominal MRI
Array genomic hybridization
Lymphokine-activated killer cell therapy and Array genomic hybridization
BUN
Lymphokine-activated killer cell therapy and BUN
Bacille Calmette-Guérin (BCG)
Lymphokine-activated killer cell therapy and Bacille Calmette-Guérin (BCG)
Beta-2 microglobulin
Lymphokine-activated killer cell therapy and Beta-2 microglobulin
Biopsy
Lymphokine-activated killer cell therapy and Biopsy
Biopsy skin
Lymphokine-activated killer cell therapy and Biopsy skin
Bladder tumor antigen (BTA)
Lymphokine-activated killer cell therapy and Bladder tumor antigen (BTA)
Brachytherapy
Sealed source radiotherapy
Lymphokine-activated killer cell therapy and Brachytherapy
Brain MRI
Lymphokine-activated killer cell therapy and Brain MRI
Breast Self Exams
Lymphokine-activated killer cell therapy and Breast Self Exams
Brush Cytology
Lymphokine-activated killer cell therapy and Brush Cytology
CA 125 (cancer antigen 125)
Lymphokine-activated killer cell therapy and CA 125 (cancer antigen 125)
CA 15-3 (cancer antigen 15.3)
Lymphokine-activated killer cell therapy and CA 15-3 (cancer antigen 15.3)
CA 19-9 (cancer antigen 19-9)
Lymphokine-activated killer cell therapy and CA 19-9 (cancer antigen 19-9)
CA 27.29 ((cancer antigen 27.29)
Lymphokine-activated killer cell therapy and CA 27.29 ((cancer antigen 27.29)
CA 72-4 (cancer antigen 72-4)
Lymphokine-activated killer cell therapy and CA 72-4 (cancer antigen 72-4)
CT Guided Needle Biopsy
Lymphokine-activated killer cell therapy and CT Guided Needle Biopsy
CT Pelvis
Lymphokine-activated killer cell therapy and CT Pelvis
for more please login, login is free (click to login)
related medication for 'lymphokine-activated killer cell therapy'/associated diagnoses
1 - 5 of
171
drugs
5-fluorouracil (5-fu)
Lymphokine-activated killer cell therapy and 5-fluorouracil (5-fu)
6-mercaptopurine (6-mp)
Lymphokine-activated killer cell therapy and 6-mercaptopurine (6-mp)
actinomycin-d
Lymphokine-activated killer cell therapy and actinomycin-d
alemtuzumab
Lymphokine-activated killer cell therapy and alemtuzumab
alkylating agents
Lymphokine-activated killer cell therapy and alkylating agents
altretamine
Lymphokine-activated killer cell therapy and altretamine
anastrozole
Lymphokine-activated killer cell therapy and anastrozole
anti tumor antibiotics
Lymphokine-activated killer cell therapy and anti tumor antibiotics
antimetabolites
Lymphokine-activated killer cell therapy and antimetabolites
arsenic trioxide
Lymphokine-activated killer cell therapy and arsenic trioxide
bevacizumab
Lymphokine-activated killer cell therapy and bevacizumab
bexarotene
Lymphokine-activated killer cell therapy and bexarotene
bicalutamide
Lymphokine-activated killer cell therapy and bicalutamide
bleomycin
Lymphokine-activated killer cell therapy and bleomycin
bortezomib
Lymphokine-activated killer cell therapy and bortezomib
busulfan
Lymphokine-activated killer cell therapy and busulfan
capecitabine
Lymphokine-activated killer cell therapy and capecitabine
carmustine (bcnu)
Lymphokine-activated killer cell therapy and carmustine (bcnu)
cetuximab
Lymphokine-activated killer cell therapy and cetuximab
chlorambucil
Lymphokine-activated killer cell therapy and chlorambucil
for more please login, login is free (click to login)
The following are types of physicians relevant for 'Lymphokine-activated killer cell therapy'.
related types of physicians 'family practitioner, internist, oncologist'
show local physicians
postal code
Find Local
stars represent relevance to topic not rating
more
The results are computer generated suggestions to help you find a physician. MEDgle does not recommend any particular type of physician or claim to be complete or accurate in the providers and specialties suggested.
web search results for 'lymphokine-activated killer cell therapy'?
Results
1 - 50
- Lymphokine-activated killer cell therapy
Deficiency in circulating natural killer (NK) cell subsets in common ...
T cell cytotoxicity is not suppressed, but lymphokine-activated killer cell (LAK) ... Two patients were on intramuscular immunoglobulin therapy. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1905722
www.pubmedcentral.nih.gov
-
summary
Role of human natural killer cells in health and disease.
Adhesion characteristics of human interleukin 2-activated natural killer cells. Cell Immunol. ... Ortaldo JR, Mason A, Overton R. Lymphokine-activated killer cells. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=368214
www.pubmedcentral.nih.gov
-
summary
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for ...
Adoptive T cell therapy, involving the ex vivo selection and expansion of ... (TIL) or lymphokine-activated killer cell (LAK) therapy, in which pharmacologic ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
Category:Cell biology - Wikipedia, the free encyclopedia
Cell therapy. Cell-free protein synthesis. Cell-free system ... Lymphokine-activated killer cell. Lysis. Lysis buffer. M. MAFA. Macrophage. Martinotti cell ...
http://en.wikipedia.org/wiki/Category:Cell_biology
en.wikipedia.org
-
summary
Renal Cell Cancer Treatment - National Cancer Institute
... Renal Cell Cancer. Local Therapy. Cytokine Therapy. Antiangiogenic Therapy ... 2 plus lymphokine-activated killer cells for advanced renal cell carcinoma. ...
http://www.nci.nih.gov/cancertopics/pdq/treatment/renalcell/...
www.nci.nih.gov
-
summary
Microsoft Word - NCI Manuscript_FINAL 10-4-07.doc
... T cell proliferation and the induction of lymphokine-activated killer cells. ... IL-7 therapy dramatically alters peripheral T cell homeostasis in normal and SIV ...
http://dcb.nci.nih.gov/ImmunAgentWork/Details_Tcell_Growth_Factors.cfm
dcb.nci.nih.gov
-
summary
Renal Cell Cancer
... is the accepted, often curative therapy for this stage of renal cell cancer. ... 2 plus lymphokine-activated killer cells for advanced renal cell carcinoma. ...
http://www.webmd.com/content/article/6/1680_51534.htm
www.webmd.com
-
summary
In vivo migration of labeled autologous natural killer cells to liver ...
... placement of autologous lymphokine-activated killer (LAK) cells after resection ... T. Autologous natural killer cell therapy for human recurrent malignant ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1681349
www.pubmedcentral.nih.gov
-
summary
CRISP - Computer Retrieval of Information on Scientific Projects ...
... patients may be due to tumor resistance and/or inadequate effector cell response. ... cellular therapies with lymphokine activated killer cells (LAK) or tumor ...
http://crisp.cit.nih.gov/crisp/CRISP_LIB.getdoc?textkey=7110...
crisp.cit.nih.gov
-
summary
Dendritic cell - Wikipedia, the free encyclopedia
... a reservoir which also would have to be targeted by a therapy. ... Natural killer cells (Lymphokine-activated killer cell) Null cell. Myeloid ? WBC ...
http://en.wikipedia.org/wiki/Dendritic_cell
en.wikipedia.org
-
summary
Clinical Trials (PDQ®) - National Cancer Institute
Lymphokine-activated killer cell therapy. Gene therapy. Chemotherapy: ... The therapy or test described in this clinical trial is intended for use by ...
http://www.nci.nih.gov/clinicaltrials/NABTT-2116
www.nci.nih.gov
-
summary
Unfractionated spleen cells but not natural killer (NK) cells from RFM ...
Successful therapy was associated with the suppression of formation of ... Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1454753
www.pubmedcentral.nih.gov
-
summary
eMedicine - Renal Cell Carcinoma : Article by Kush Sachdeva
... cell cancer are surgery, radiation therapy, chemotherapy, hormonal therapy, ... lymphokine- activated killer cells in the treatment of patients with advanced ...
http://www.emedicine.com/med/topic2002.htm
www.emedicine.com
-
summary
Clinical Study: 97-H-0196, A Phase II Study of HLA-Matched Peripheral ...
... are usually combined with powerful doses of chemotherapy and radiation therapy. ... lymphokine activated killer cells among primary and metastatic renal cell ...
http://clinicalstudies.info.nih.gov/detail/A_1997-H-0196.html
clinicalstudies.info.nih.gov
-
summary
NCI Drug Dictionary - National Cancer Institute
In antibody-directed enzyme prodrug therapy (ADEPT), this agent is conjugated ... interleukin-2-mediated lymphokine-activated killer cell function and may augment ...
http://nci.nih.gov/templates/drugdictionary.aspx?expand=G
nci.nih.gov
-
summary
Renal Cell Cancer
... 2), with or without lymphokine-activated killer lymphocytes, appeared to have a ... High-dose therapy appears to be associated with higher response rates but with ...
http://www.webmd.com/cancer/tc/ncicdr0000062894-stage-iv-and...
www.webmd.com
-
summary
List of oncology-related terms - Wikipedia, the free encyclopedia
... cell. antigen-presenting cell vaccine. antiglobulin test. antihormone therapy ... lymphokine-activated killer cell. lymphoma. lymphomatoid granulomatosis ...
http://en.wikipedia.org/wiki/List_of_oncology-related_terms
en.wikipedia.org
-
summary
NCI Drug Dictionary - National Cancer Institute
... interleukin-2-mediated lymphokine-activated killer cell function; it may also ... known as boron neutron capture therapy (BNCT), spares adjacent normal tissues. ...
http://cnetdb.nci.nih.gov/templates/drugdictionary.aspx?expand=S
cnetdb.nci.nih.gov
-
summary
Methionine enkephalin: activation of NK-K-LAK cells in AIDS patients.
... was recorded by NK cell functional activity against K562, and ... Killer Cells. Killer Cells, Lymphokine-Activated. Killer Cells, Natural. Receptors, IgG ...
http://gateway.nlm.nih.gov/MeetingAbstracts/ma?f=102192744.html
gateway.nlm.nih.gov
-
summary
NCI Drug Dictionary - National Cancer Institute
... emission tomography (PET) may help predict responses to topotecan therapy. ... lymphokine-activated killer (LAK) cell and natural killer (NK) cell activities, ...
http://wwwicic.nci.nih.gov/templates/drugdictionary.aspx?expand=All
wwwicic.nci.nih.gov
-
summary
Human Natural Killer Cells Mediate Killing of Intracellular ...
Two-color fluorescence-activated cell sorter analysis using CD3 ... are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=98082
www.pubmedcentral.nih.gov
-
summary
NIH Guide: HUMAN STEM CELL SOURCES AND TRANSPLANTATION BIOLOGY
... natural killer cells, and lymphokine-activated killer cells from the various ... as cord blood versus bone marrow, to serve as cellular vehicles for gene therapy. ...
http://grants.nih.gov/grants/guide/rfa-files/RFA-HL-95-008.html
grants.nih.gov
-
summary
Newcastle Disease Virus - National Cancer Institute
... during therapy showed increases in the numbers of natural killer cells and ... Autologous tumor-cell vaccination and lymphokine-activated tumor-infiltrating ...
http://www.nci.nih.gov/cancertopics/pdq/cam/NDV/HealthProfessional/160.cdr
www.nci.nih.gov
-
summary
Blood plasma - Wikipedia, the free encyclopedia
... is a type of medical therapy involving separation of plasma from red ... Natural killer cells (Lymphokine-activated killer cell) Null cell. Myeloid ? WBC ...
http://en.wikipedia.org/wiki/Blood_plasma
en.wikipedia.org
-
summary
Enhancement of interleukin-2 immunotherapy with L-arginine.
Interleukin-2 therapy in mice receiving dietary arginine compared with those ... Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1242404
www.pubmedcentral.nih.gov
-
summary
Peri-operative modulation of cellular immunity in patients with ...
... Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. ... Goldstein D, Laszlo J. Interferon therapy in cancer: from imaginon to ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1534352
www.pubmedcentral.nih.gov
-
summary
Eosinophil granulocyte - Wikipedia, the free encyclopedia
monoclonal antibody therapy against IL-5 - promote apoptosis ... Natural killer cells (Lymphokine-activated killer cell) Null cell. Myeloid - WBC ...
http://en.wikipedia.org/wiki/Eosinophil
en.wikipedia.org
-
summary
Combination chemo-immunotherapy: kinetics of in vivo and in vitro ...
... 2 (IL-2) induced lymphokine-activated killer (LAK) cell activity was examined. ... of timing in cyclophosphamide therapy of MOPC-315 tumor-bearing ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1534943
www.pubmedcentral.nih.gov
-
summary
Mesothelioma - Wikipedia, the free encyclopedia
... killer cell lysis and significantly reduce lymphokine-activated killer cell ... Radiation therapy when given alone with curative intent has never been shown to ...
http://en.wikipedia.org/wiki/Mesothelioma
en.wikipedia.org
-
summary
Increased LAK activity against HIV-infected cell lines in HIV-1 ...
... combined recombinant interleukin-2 and LAK cell therapy. J Clin Oncol. ... Diminution of inducible lymphokine-activated killer cell activity in individuals ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1554484
www.pubmedcentral.nih.gov
-
summary
Effects of tumour necrosis factor-alpha (TNF-alpha), IL-1 beta and ...
... Phase I evaluation of combination therapy with interleukin 2 and gamma ... Regulation of lymphokine-activated killer cell induction by human recombinant IL ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1554840
www.pubmedcentral.nih.gov
-
summary
eMedicine - Immunotherapeutic Targeting : Article by Robert J Arceci ...
... DL, Antin JH: The graft-versus-leukemia effects of allogeneic cell therapy. ... cancer using lymphokine-activated killer cells and interleukin-2 or high-dose ...
http://www.emedicine.com/ped/topic2728.htm
www.emedicine.com
-
summary
List of AIDS-related topics - Wikipedia, the free encyclopedia
B cell lymphoma - B cells - B lymphocytes (B cells) - bactericidal ... lymphoid tissue - lymphokine-activated killer cells (LAK) - lymphokines ...
http://en.wikipedia.org/wiki/List_of_AIDS-related_topics
en.wikipedia.org
-
summary
Cytotoxic T lymphocytes with a grafted recognition specificity for ...
Fox BA, Rosenberg SA. Heterogeneous lymphokine-activated killer cell precursor populations. ... Adoptive T cell therapy of tumors: mechanisms operative in the ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?&artid=43776
www.pubmedcentral.nih.gov
-
summary
Flowcytometry ? A rapid tool to correlate functional activities of ...
... sub-populations to the Lymphokine Activated Killer (LAK) phenomenon. ... GM-CSF enhances IL-2-activated natural killer cell lysis of clonogenic AML cells ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=122086
www.pubmedcentral.nih.gov
-
summary
Clinical course and immune response of a renal cell carcinoma patient ...
... the enhancement of CTL inducibility secondary to adoptive T cell therapy, ... activated killer cell cytotoxic activity in tumor cell killing determined by ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1808870
www.pubmedcentral.nih.gov
-
summary
PHASE I STUDY OF TUMOR-INFILTRATING LYMPHOCYTES DERIVED FROM IN VIVO HLA-B7
such as melanoma, renal cell carcinoma and colon adenocarcinoma are responsive to immunotherapy ... lymphokine-activated killer (LAK) cells (3) ...
http://www4.od.nih.gov/oba/rac/abstracts/120_s.pdf
www4.od.nih.gov
-
summary
Coexpression of two distinct genes is required to generate secreted ...
... administration of autologous lymphokine-activated killer cells and recombinant ... purification of natural killer cell stimulatory factor (NKSF), a cytokine with ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=51614
www.pubmedcentral.nih.gov
-
summary
Purification to homogeneity and partial characterization of cytotoxic ...
... effects of combination therapy with human recombinant interleukin ... 2 in the generation of human lymphokine-activated killer cell cytotoxicity. Cancer Res. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=54627
www.pubmedcentral.nih.gov
-
summary
www.nci.nih.gov/templates/db_alpha.aspx?print=1&expand=L
Also called a lymphokine-activated killer cell. lamina propria ... light-emitting diode therapy (lite-ee-MIT-ing THAYR-uh-pee) ... lymphokine-activated killer cell ...
http://www.nci.nih.gov/templates/db_alpha.aspx?print=1&expand=L
www.nci.nih.gov
-
summary
Lack of protection against bacterial infections in patients with ...
Prior to the initiation of therapy, all patients were infection free and not ... Mazumder A, Zhang HZ, Rosenberg SA. Lymphokine-activated killer cell phenomenon. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pubmed&pubmedid=2584381
www.pubmedcentral.nih.gov
-
summary
Differential augmentation of in vivo natural killer cytotoxicity in ...
... the induction of human IL-2 induced lymphokine activated killer (LAK) activity. ... Natural killer cell-mediated antitumor reactivity of rhesus monkeys. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1534954
www.pubmedcentral.nih.gov
-
summary
Role of vaccine therapy in cancer: biology and practice
... adoptive cell transfer techniques using either lymphokine-activated killer cells ... in conjunction with lymphokine-activated killer cells for the treatment of ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2133100
www.pubmedcentral.nih.gov
-
summary
(2) T-
lymphokine-activated killer cells. Proc Natl Acad Sci U S A, ... (IL)-15R alpha and IL-15 supports natural killer cell and memory ... cell therapy is ...
http://dcb.nci.nih.gov/ImmunAgentWork/Details_Tcell_Growth_Factors.pdf
dcb.nci.nih.gov
-
summary
Renal cell cancer: Treatment - Health Professional Information [NCI PDQ ...
... is the accepted, often curative, therapy for this stage of renal cell cancer. ... 2 plus lymphokine-activated killer cells for advanced renal cell carcinoma. ...
http://health.yahoo.com/cancer-treatment/renal-cell-cancer-t...
health.yahoo.com
-
summary
Interferon gamma induces lung colonization by intravenously inoculated ...
... tumor cell clearance and in relation to lymphokine-based strategies for therapy. ... Dissection of the lymphokine-activated killer phenomenon. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=304879
www.pubmedcentral.nih.gov
-
summary
Immunological Effects of Interleukin-2 Therapy in Human ...
... is essential for the induction of lymphokine-activated killer cells (38, 41, 63) ... spontaneous and activation-induced cell death after 4 weeks of therapy. ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pub...
www.pubmedcentral.nih.gov
-
summary
Immune and Genetic Therapies for Advanced Renal Cell Carcinoma
... cellular therapy by utilizing nonspecific lymphokine-activated killer (LAK) ... Natural history and therapy of metastatic renal cell carcinoma: the role of ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1476086
www.pubmedcentral.nih.gov
-
summary
IFN-? protects short-term ovarian carcinoma cell lines from CTL lysis ...
... cell lines that were established at the Immune and Gene Therapy Laboratory ... cell line (OVAC); tumor-associated lymphocyte (TAL); lymphokine activated killer ...
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=151808
www.pubmedcentral.nih.gov
-
summary
NCI Drug Dictionary - National Cancer Institute
... T-lymphocytes, such as lymphokine-activated killer cells, and increasing levels ... secretion of and IFN-alpha and -beta induce natural killer (NK) cell ...
http://www.nci.nih.gov/Templates/drugdictionary.aspx?expand=I&page=1&print=1
www.nci.nih.gov
-
summary
show more
1
2
Chat with eNurse Kim about 'Lymphokine-activated killer cell therapy' or something else!
quick facts
related diagnosis category
oncology
faq/about
|
disclaimer
|
privacy policy
|
terms of service
|
browse
|
beta
|
contact
|
API - Catalyst
MEDgle does not provide medical advice, diagnosis or treatment. Copyright 2006-2012, MEDgle Inc. All Rights Reserved. MEDgle is NOT affiliated with Google. Last Updated: Mar 14, 2012
This site complies to the
HONcode standard for trustworthy health
information:
verify here
.
Invited Sponsor for Communications Conference
Finalist -- search & reference
MEDgle has been selected for the 2009 Best of Business Award in the Medical research